Tags

Type your tag names separated by a space and hit enter

Medical nanorobotics for diabetes control.
Nanomedicine. 2008 Jun; 4(2):127-38.N

Abstract

This work presents an innovative nanorobot architecture based on nanobioelectronics for diabetes. The progressive development toward the therapeutic use of nanorobots should be observed as the natural result from some ongoing and future achievements in biomedical instrumentation, wireless communication, remote power transmission, nanoelectronics, new materials engineering, chemistry, proteomics, and photonics. To illustrate the nanorobot integrated circuit architecture and layout described here, a computational approach with the application of medical nanorobotics for diabetes is simulated using clinical data. Integrated simulation can provide interactive tools for addressing nanorobot choices on sensing, hardware design specification, manufacturing analysis, and methodology for control investigation. In the proposed 3D prototyping, a physician can help the patient to avoid hyperglycemia by means of a handheld device, like a cell phone enclosed with cloth, that is used as a smart portable device to communicate with nanorobots. Therefore, this architecture provides a suitable choice to establish a practical medical nanorobotics platform for in vivo health monitoring.

Authors+Show Affiliations

CAN Center for Automation in Nanobiotech, Melbourne VIC, Australia. adrianocavalcanti@canbiotechnems.comNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18455965

Citation

Cavalcanti, Adriano, et al. "Medical Nanorobotics for Diabetes Control." Nanomedicine : Nanotechnology, Biology, and Medicine, vol. 4, no. 2, 2008, pp. 127-38.
Cavalcanti A, Shirinzadeh B, Kretly LC. Medical nanorobotics for diabetes control. Nanomedicine. 2008;4(2):127-38.
Cavalcanti, A., Shirinzadeh, B., & Kretly, L. C. (2008). Medical nanorobotics for diabetes control. Nanomedicine : Nanotechnology, Biology, and Medicine, 4(2), 127-38. https://doi.org/10.1016/j.nano.2008.03.001
Cavalcanti A, Shirinzadeh B, Kretly LC. Medical Nanorobotics for Diabetes Control. Nanomedicine. 2008;4(2):127-38. PubMed PMID: 18455965.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Medical nanorobotics for diabetes control. AU - Cavalcanti,Adriano, AU - Shirinzadeh,Bijan, AU - Kretly,Luiz C, Y1 - 2008/05/02/ PY - 2007/06/30/received PY - 2008/03/05/revised PY - 2008/03/16/accepted PY - 2008/5/6/pubmed PY - 2008/7/11/medline PY - 2008/5/6/entrez SP - 127 EP - 38 JF - Nanomedicine : nanotechnology, biology, and medicine JO - Nanomedicine VL - 4 IS - 2 N2 - This work presents an innovative nanorobot architecture based on nanobioelectronics for diabetes. The progressive development toward the therapeutic use of nanorobots should be observed as the natural result from some ongoing and future achievements in biomedical instrumentation, wireless communication, remote power transmission, nanoelectronics, new materials engineering, chemistry, proteomics, and photonics. To illustrate the nanorobot integrated circuit architecture and layout described here, a computational approach with the application of medical nanorobotics for diabetes is simulated using clinical data. Integrated simulation can provide interactive tools for addressing nanorobot choices on sensing, hardware design specification, manufacturing analysis, and methodology for control investigation. In the proposed 3D prototyping, a physician can help the patient to avoid hyperglycemia by means of a handheld device, like a cell phone enclosed with cloth, that is used as a smart portable device to communicate with nanorobots. Therefore, this architecture provides a suitable choice to establish a practical medical nanorobotics platform for in vivo health monitoring. SN - 1549-9642 UR - https://www.unboundmedicine.com/medline/citation/18455965/Medical_nanorobotics_for_diabetes_control_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1549-9634(08)00034-8 DB - PRIME DP - Unbound Medicine ER -